Exalenz Bioscience

Founded: 2006 • Age: 20 yrs Acquired By Meridian Bioscience
Breath gas analysis to detect H pylori infection and diagnose Gastric and hepatocellular cancer
Request Access

About Exalenz Bioscience

Exalenz Bioscience is a company founded in 2006 was acquired by Meridian Bioscience in February 2020.. Exalenz Bioscience operates in a competitive market with competitors including Mauna Kea Tech, EchoSens, CapsoVision, Smart Medical Systems and Invendo Medical, among others.

  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Exalenz Bioscience

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Exalenz Bioscience

Exalenz Bioscience has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Meridian Bioscience. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Molecular diagnostic device and kits
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Exalenz Bioscience

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Exalenz Bioscience

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Exalenz Bioscience Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Exalenz Bioscience

Exalenz Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Mauna Kea Tech, EchoSens, CapsoVision, Smart Medical Systems and Invendo Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Endomicroscopy devices are developed for gastrointestinal and respiratory endoscopy.
domain founded_year HQ Location
Non-invasive diagnostics for liver disease detection are developed.
domain founded_year HQ Location
GI capsule endoscopy systems are developed for intestinal imaging.
domain founded_year HQ Location
Endoscopes and devices for GI diagnosis and treatment are produced.
domain founded_year HQ Location
Sterile single-use robotics-based endoscopes are developed for gastroenterology.
domain founded_year HQ Location
Devices for GI disorder diagnosis and treatment are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Exalenz Bioscience

Frequently Asked Questions about Exalenz Bioscience

When was Exalenz Bioscience founded?

Exalenz Bioscience was founded in 2006.

What does Exalenz Bioscience do?

Exalenz Bioscience was founded in 2006 and focuses on medical diagnostics in the gastrointestinal and liver disorder sector. Non-invasive breath analysis systems are developed and commercialized by the company to identify H. pylori bacteria, a key factor in peptic ulcers and gastric cancer risks. Hepatocellular cancer monitoring is also enabled by the technology. Regulatory approvals have been obtained in the USA, Europe, and China, with tests completed in 10-15 minutes.

Who are the top competitors of Exalenz Bioscience?

Exalenz Bioscience's top competitors include EchoSens, CapsoVision and Mauna Kea Tech.

Who are Exalenz Bioscience's investors?

Exalenz Bioscience has 1 investor. Key investors include Meridian Bioscience.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available